Year
2025202420232022202120202019201820172016201520142012201120102009200820072006200520042003200220012000
Edition number
№20 (273)№19 (272)№18 (271)№s5-13№16 (269)№15 (268)№s4-13№s3-13№14 (267)№13 (266)№12 (265)№11 (264)№10 (263)№9 (262)№s2-13№5 (258)№8 (261)№7 (260)№6 (259)№4 (257)№3 (256)№2 (255)№s1-13№1 (254)
№17 (270) / 2013
L.V. Filatova
DRUG THERAPY OF HODGKIN'S LYMPHOMA10-14
L.V. Manzyuk
MODERN APPROACH TO THE SYSTEMIC DRUG TREATMENT OF BONE METASTASES15-19
E.V. Bakhidze
CURRENT APPROACHES TO THE DIAGNOSIS, TREATMENT AND PROGNOSIS OF OVARIAN GRANULOSA CELL TUMORS (ANALYSIS OF THE LITERATURE DATA AND OWN RESEARCH)20-25
L.V.Bolotina, A.L. Kornietskaya , T.I. Deshkina
COMPARATIVE ANALYSIS OF THE IMMEDIATE EFFECTIVENESS OF THREE COMPONENT (ANTHRACYCLINE-CONTAINING) AND TWO-COMPONENT (NO ANTHRACYCLINE-CONTAINING) REGIMENS OF INDUCTION CHEMOTHERAPY FOR LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA26-29
M.R. Lichinitser, M.E. Abramov, Z.G. Kadagidze, E.G. Slavina
REFNOT® – A NOVEL IMMUNOMODULATOR FOR THE TREATMENT OF CANCER PATIENTS30-33
Zaitsev A.M. 1, Abuzarova G.R. 2, Kirsanova O.N. 1, Sarmanaeva R.R. 1, Kurzhupov M.I. 1, Samarin A.E. 1
IMPLANTABLE MORPHINE PUMPS IN THE TREATMENT OF CHRONIC PAIN IN CANCER PATIENTS. THE FIRST CLINICAL EXPERIENCE34-39
Z.G. Kadagidze, E.G. Slavina, A.I. Chertkova
INTERFERON-GAMMA IN ONCOLOGY40-44
O.V. Salafet 1, T.V. Chernovskaya 1 , L.P. Sheveleva 2 , A.V. Khorinko 3 , T.I. Prokopenko3, M.N. Nechayeva 4, O.N. Burdayeva 4 , M.P. Matrosova 5, N.V. Kovalenko 6 , I.A. Koroleva7, R.A. Ivanov 1
EFFICACY AND SAFETY OF EXTIMIA®, A NEW PEGYLATED FILGRASTIM: RESULTS OF OPEN COMPARATIVE PHASE II CLINICAL TRIAL IN PATIENTS WITH BREAST CANCER RECEIVING MYELOSUPPRESSIVE CHEMOTHERAPY46-48
M.B. Stenina
ERIBULIN - NEW MICROTUBULE INHIBITOR FOR THE TREATMENT OF METASTATIC BREAST CANCER49-56
T.Yu. Semiglazova 1 , V.V. Semiglazov 2 , L.V. Filatov 1 , P.V. Krivorotko 1 , V.V. Klimenko 1, V.G. Ivanov 1 , S.M. Novikov 1 , M.L. Gershanovich 1 , E.N. Imyanitov 1, V.F. Semiglazov 1
IMPORTANCE OF MOLECULAR MARKERS IN CHOOSING OF NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER57-64
E.V. Bakhidze
HORMONE THERAPY FOR METASTATIC AND RECURRENT ENDOMETRIAL CANCER65-69
D.R. Markar'yan 1, 2, P.V. Tsarkov 1, 2, E.R. Minnibayeva 1
FEATURES OF PREOPERATIVE PREPARATION AND MANAGEMENT OF SENILE PATIENTS WITH COLORECTAL CANCER70-74
Yu.A. Alekseeva, R.I. Vabishchevich
THE CASE OF TOTAL LYMPHOMATOID GASTROINTESTINAL POLYPOSIS AGAINST THE BACKGROUND OF MANTLE ZONE LYMPHOMA75-79
